Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
| ▸ | CTSV | O60911 | 1/20 | 0.51 |
| ▸ | CTSL | P07711 | 1/20 | 0.51 |
| ▸ | AKR1C3 | P42330 | 4/20 | 0.51 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.51 |
| ▸ | MPO | P05164 | 1/20 | 0.51 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.48 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3279807 | 0.88 | MAPT (0.72) | SMN1; SMN2MAPTALDH1A1KMT2ACYP19A1 | |
| SCHEMBL3606284 | 0.85 | SMN1; SMN2 (0.76) | SMN1; SMN2MAPTALDH1A1KMT2ACYP19A1 | |
| SCHEMBL10542066 | 0.84 | ALDH1A1 (0.55) | SMN1; SMN2MAPTALDH1A1CYP3A4ALOX15 | |
| SCHEMBL7974577 | 0.84 | ALDH1A1 (0.55) | SMN1; SMN2MAPTALDH1A1CYP3A4ALOX15 | |
| SCHEMBL3694733 | 0.84 | MAPT (0.77) | SMN1; SMN2MAPTALDH1A1CYP3A4ALOX15 | |
| SCHEMBL12703765 | 0.84 | KMT2A (0.61) | SMN1; SMN2MAPTALDH1A1CYP3A4ALOX15 | |
| SCHEMBL1663739 | 0.84 | MAPT (0.56) | SMN1; SMN2MAPTALDH1A1CYP3A4ALOX15 | |
| SCHEMBL14574207 | 0.84 | MAPT (0.55) | SMN1; SMN2MAPTALDH1A1CYP3A4ALOX15 | |
| SCHEMBL18499349 | 0.83 | LMNA (0.53) | SMN1; SMN2MAPTALDH1A1CYP3A4ALOX15 | |
| SCHEMBL2031092 | 0.83 | KCNK2 (0.64) | SMN1; SMN2MAPTALDH1A1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115850100-B | Preparation method of 2-amino-4-nitrobenzoic acid | 武汉强丰新特科技有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-117510414-A | Preparation method of hypnone hapten and complete antigen | 深圳市质量安全检验检测研究院(深圳市动物疫病预防控制中心) | 2024-02-06 | — | — | CN | claimed |
| CN-115850100-A | Preparation method of 2-amino-4-nitrobenzoic acid | 武汉强丰新特科技有限公司 | 2023-03-28 | — | — | CN | claimed |
| WO-2025064325-A1 | GPR35 MODULATORS | PROMETHEUS BIOSCIENCES, INC. (US) | 2025-03-27 | — | — | WO | disclosed |
| CN-115850100-B | Preparation method of 2-amino-4-nitrobenzoic acid | 武汉强丰新特科技有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-115850100-B | Preparation method of 2-amino-4-nitrobenzoic acid | 武汉强丰新特科技有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-117510414-A | Preparation method of hypnone hapten and complete antigen | 深圳市质量安全检验检测研究院(深圳市动物疫病预防控制中心) | 2024-02-06 | — | — | CN | disclosed |
| CN-115850100-A | Preparation method of 2-amino-4-nitrobenzoic acid | 武汉强丰新特科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-115850100-A | Preparation method of 2-amino-4-nitrobenzoic acid | 武汉强丰新特科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20070054909-A1 | VLA-4 inhibitor compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-03-08 | — | — | US | disclosed |
| US-7179819-B2 | VLA-4 inhibitor compounds | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-02-20 | — | — | US | disclosed |
| WO-1997010221-A1 | SYNTHESIS OF QUINAZOLINONE LIBRARIES | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1997-03-20 | — | — | WO | disclosed |
| EP-0317645-B1 | 4H-3,1-BENZOXAZIN-4-ONE COMPOUNDS AND SERINE PROTEASE-INHIBITING MEDICINAL COMPOSITION CONTAINING SAME | TEIJIN LIMITED (JP) | 1993-09-15 | — | — | EP | disclosed |
| US-5187167-A | Antitumor agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-02-16 | — | — | US | disclosed |
| US-5081124-A | Amino acid and polyamino acid derivatives, inhibitors of thymidylate synthetase | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-01-14 | — | — | US | disclosed |
| EP-0239362-B1 | ANTI-TUMOR AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-12-04 | — | — | EP | disclosed |
| US-4980287-A | ANTIINFLAMMATORY AGENTS; INHIBITOR OF DEGENERATION AND DESTRUCTION OF TISSUES | TEIJIN LIMITED (JP) | 1990-12-25 | — | — | US | disclosed |
| EP-0317645-A1 | 4H-3,1-BENZOXAZIN-4-ONE COMPOUNDS AND SERINE PROTEASE-INHIBITING MEDICINAL COMPOSITION CONTAINING SAME | TEIJIN LIMITED (JP) | 1989-05-31 | — | — | EP | disclosed |
| EP-0239362-A2 | Anti-tumor agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-09-30 | — | — | EP | disclosed |
| US-4307113-A | TREATMENT OF DIABETES | SANDOZ, INC. (US) | 1981-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070054909-A1 | VLA-4 inhibitor compounds | VCAM1, ITGB4, ICAM1 | SMN1; SMN2 4245/4885MAPT 3296/4885ALDH1A1 120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.